(Q43183525)

15 November 2017

Selectivity of action of 8-alkylamino analogues of N6-cyclopentyladenosine in vivo: haemodynamic versus anti-lipolytic responses in rats (English)

1 reference

15 November 2017

1 reference

4

1 reference

15 November 2017

5

Danhof M

1 reference

15 November 2017

van Schaick EA

1

1 reference

15 November 2017

Tukker HE

series ordinal

2

1 reference

15 November 2017

Roelen HC

series ordinal

3

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

British Journal of Pharmacology

15 November 2017

1 reference

15 November 2017

124

1 reference

15 November 2017

3

1 reference

15 November 2017

607-618

1 reference

Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline

15 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

Regulation of GH3-cell function via adenosine A1 receptors. Inhibition of prolactin release, cyclic AMP production and inositol phosphate generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

Functional characterization of three adenosine receptor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development. The "wooden shoe' paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Comparison of four basic models of indirect pharmacodynamic responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Calcium-dependent currents in cultured rat dorsal root ganglion neurones are inhibited by an adenosine analogue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Effect of fatty acids on glucose production and utilization in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

The effects of GR79236 on plasma fatty acid concentrations, heart rate and blood pressure in the conscious rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Kinetics of pharmacologic response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Partial agonism of theophylline-7-riboside on adenosine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Physiologic indirect response models characterize diverse types of pharmacodynamic effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Biological activities of N6,C8-disubstituted adenosine derivatives as partial agonists at rat brain adenosine A1 receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

High-performance liquid chromatography of the adenosine A1 agonist N6-cyclopentyladenosine and the A1 antagonist 8-cyclopentyltheophylline and its application in a pharmacokinetic study in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Cardiovascular and antilipolytic effects of the adenosine agonist GR79236

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Cardiovascular purinoceptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Differential A1 adenosine receptor reserve for two actions of adenosine on guinea pig atrial myocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

N6-substituted adenosine receptor agonists: potential antihypertensive agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Pharmacokinetic-pharmacodynamic modelling of the anti-lipolytic and anti-ketotic effects of the adenosine A1-receptor agonist N6-(p-sulphophenyl)adenosine in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701868

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701868

1 reference

15 November 2017

1 reference

15 November 2017

1 reference